India's Strides Arcolab in New Anti-Infectives Deal

Indian outsourced drugmaker Strides Arcolab has announced a further agreement with Australian drug producer Mayne Group. The deal envisages production of six anti-infective products to be distributed by Mayne in the US, and follows an earlier development deal late last year for six specialised injectable products. Strides Arcolab claims that the earlier agreement targets a market worth US$350mn per year.